MIAMISBURG, Ohio, Jan. 13, 2020 /PRNewswire/ -- Verso Corporation
(NYSE: VRS) ("Verso" or the "Company") today announced that the
Verso Board of Directors has sent a letter to stockholders in
connection with the Company's upcoming 2019 Annual Meeting of
Stockholders, to be held on January 31,
2020. As previously disclosed, the Annual Meeting will
include proposals related to the sale of Verso's Androscoggin and
Stevens Point mills to Pixelle Specialty Solutions (the "Pixelle
Transaction"). Verso stockholders of record at the close of
business on December 16, 2019 are
entitled to attend and vote at the Annual Meeting. The Company's
proxy statement and other important information related to the
Annual Meeting can be found online at
http://www.stockholderdocs.com/VRS.
Verso's Board of Directors (the "Board") unanimously recommends
that stockholders vote "FOR" ALL seven of Verso's nominees,
"FOR" the approval of the Pixelle Transaction (Company Proposal
2), and "FOR" Company Proposals 3 - 8 on the WHITE proxy
card TODAY.
Today the Verso Board will mail the following letter to
stockholders:
January 13,
2020
Dear Fellow Stockholders,
Our Annual Meeting for
Stockholders to be held on January 31,
2020, is rapidly approaching, and your vote is critical to
the future of the Company, no matter how many shares you own. The
Board of Directors unanimously recommends that you vote "FOR" ALL
seven of Verso's nominees and "FOR" the approval of the Pixelle
Transaction (Company Proposal 2) on the WHITE proxy card
TODAY.
Your vote is very
important. You are entitled to have accurate and reliable
information on which to base your decision. We are writing this
letter to provide you with facts that dispel and negate Atlas/Blue
Wolf's contrived mischaracterizations of our Company. We want to
set the record straight about the significant value that our
proposed Board nominees will create for Verso in the near and
long term.
EVERY "FOR" VOTE IS
CRITICAL TO APPROVE THE PIXELLE TRANSACTION
ATLAS/BLUE WOLF'S ABSTENTION ON THE PIXELLE TRANSACTION
HAS THE
SAME IMPACT AS VOTING "AGAINST" SINCE VERSO REQUIRES AN
AFFIRMATIVE VOTE OF A MAJORITY OF THE OUTSTANDING SHARES, NOT
JUST A MAJORITY OF THE VOTES CAST AT THE ANNUAL MEETING.
ATLAS/BLUE WOLF'S ACTIONS ARE PUTTING AT LEAST $225 MILLION OF
CAPITAL RETURNS – AND THE FUTURE VALUE OF YOUR INVESTMENT – AT
RISK
We believe Atlas/Blue Wolf has
commenced its proxy contest so as to control the Company's
specialty mills without paying for them and to provide an exit
strategy for its suspected underperforming portfolio asset, Twin
Rivers Paper, by combining it with our better performing assets.
Atlas/Blue Wolf's objective is self-serving and doesn't benefit all
of Verso's stockholders.
Atlas/Blue Wolf's decision to
abstain from voting on the Pixelle Transaction clearly evidences
its self-serving agenda: it won't take a public position on the
sale because it doesn't want to admit that this is a great deal for
all of our stockholders – other than Atlas/Blue Wolf, which for the
last two years has attempted to gain control of the Stevens Point
and Androscoggin Mills without paying fair value. Atlas/Blue
Wolf's abstention is a way of voting NO on the sale and it is clear
that Atlas/Blue Wolf took this position for the sole purpose of
opposing the transaction. As outlined in our public proxy
materials, abstentions have the same effect as voting against the
transaction, since Verso requires an affirmative vote of a majority
of the outstanding shares, not just a majority of the votes cast at
the Annual Meeting. To be approved, the Pixelle Transaction
requires the affirmative vote of a majority of shares outstanding.
Your vote FOR the Pixelle Transaction is imperative.
Atlas/Blue Wolf is attempting
to persuade stockholders that its real purpose for abstaining is to
obtain more information about the Pixelle Transaction. We
believe it hopes to confuse stockholders who may not understand the
ramifications of an abstention. While an abstention may seem to be
neutral, Atlas/Blue Wolf is actively sabotaging the deal.
Stockholders should not be fooled.
Details about the transaction are
disclosed in Verso's definitive proxy materials;
- We recently publicly filed the two additional agreements that
Atlas/Blue Wolf stated it needed to review to evaluate the
transaction—there is no reason for Atlas/Blue Wolf to abstain
except to try to stop the sale;
- Atlas/Blue Wolf is stalling for time as it searches for a red
herring to kill the Pixelle Transaction;
- Atlas/Blue Wolf is spending lots of its money as it tries to
force its way into the Verso boardroom, not because its nominees
will add any value to the Company but rather because a hostile
proxy fight and litigation strategy is still significantly cheaper
than paying full and fair value for the Company or its assets;
- Atlas/Blue Wolf is forcing Verso to spend stockholders' money
on a costly and distracting proxy contest to defend your interests
and the Company's long-term stockholder value; and
- Atlas/Blue Wolf will continue searching for any possible way to
execute a deal with its own asset, Twin Rivers Paper, to the
detriment of all other stockholders.
YOUR INVESTMENT IS AT RISK. If
successful, we believe Atlas/Blue Wolf will hinder the progress
your Board and management team are making, destroy the value
potential of Verso and prevent stockholders from receiving at least
$225 million in proceeds from the
Pixelle Transaction.
WE BELIEVE ATLAS/BLUE WOLF SEEKS EFFECTIVE
CONTROL OF VERSO
BY SEEKING ELECTION OF HIGHLY CONFLICTED, NON-ADDITIVE
NOMINEES
- Consistent with best practice corporate governance principles,
our Board conducted a comprehensive assessment of Atlas/Blue Wolf's
nominees, just as it does with any potential nominees, and the
Board determined the Atlas/Blue Wolf nominees are highly conflicted
and not additive.
- Atlas/Blue Wolf has repeatedly pointed out that two of our
nominees lack paper industry-specific experience, yet one of
their own nominees, Jeffrey Kirt,
has zero experience in the paper industry.
- Unlike the activist hedge funds that typically engage in proxy
contests for board representation, Atlas/Blue Wolf are private
equity firms that own companies directly competing with
Verso.
- If elected, the Atlas/Blue Wolf nominees may intentionally
derail the Pixelle Transaction in an effort to enhance the
competitive position of Twin Rivers, a direct competitor of Verso
in coated specialty papers. Its actions could potentially
jeopardize the benefits of the Pixelle Transaction and
influence the size, timing and manner of the distribution of
proceeds.
- When the Verso Board attempted to reach a reasonable settlement
and proposed a cooperation agreement, Atlas/Blue Wolf's proposed
revisions included the ability for its nominees to freely share
material, non-public information with Atlas/Blue Wolf, implying a
level of dependency that poses a serious conflict of interest and
is highly detrimental to other stockholders.
- Atlas/Blue Wolf desperately needs effective control of Verso
and its attractive assets, so as to influence and facilitate a
possible transaction with the Company on terms favorable to
Atlas/Blue Wolf at the expense of our other stockholders, and to
camouflage the suspected underperformance of the portfolio assets
of Atlas/Blue Wolf's affiliates.
ATLAS/BLUE WOLF IS TARGETING THREE VERSO
NOMINEES WHO BRING
IMPORTANT DIVERSITY, GOVERNANCE EXPERTISE, INDUSTRY EXPERIENCE
AND INSTITUTIONAL KNOWLEDGE
TO THE VERSO BOARD
Each of the three Verso nominees
that Atlas/Blue Wolf is opposing – Steven
D. Scheiwe, Jay Shuster and
Nancy M. Taylor – brings specific
and necessary skills to the Company that are complementary and
additive to the full Board. Replacing any of these directors with
the Atlas/Blue Wolf nominees would remove diversity, skills and
experience from the Board that are important to Verso's continued
success.
Additionally, Mr. Scheiwe, Mr.
Shuster and Ms. Taylor have operational experience transforming
companies, some of which includes turnarounds in the paper industry
to adapt to changing industry dynamics and meet market demands. We
believe their specific skills will support Verso's continued
trajectory, transformation and the outperformance of our peers.
Steven
D. Scheiwe
Verso Independent Director Since 2016,
since the Company emerged from bankruptcy
President of Ontrac Advisors, Mr.
Scheiwe is an expert in managing distressed debt issues for private
equity firms, companies and funds.
- Gained substantial knowledge of business planning and
execution, M&A, finance and other aspects of managing a
business enterprise
- Service as a director of several public and private companies
across a wide spectrum of industries provides him with diverse
experiences
- As a member of the Board since the Company's emergence from
bankruptcy in 2016, Mr. Scheiwe has played an integral role in
Verso's outperformance of both the Company's peer group and the
Russell 2000, with 49% stock appreciation over the last three
years
Nancy
M. Taylor
Verso Independent Director Since
2019
Ms. Taylor has more than 20 years
of experience in senior management, in both operational and
commercial leadership roles with manufacturing companies, and as
chief executive officer of a publicly traded global
manufacturer.
- Brings unique experience as a former public company CEO, having
successfully implemented a growth and market diversification
strategy as well as a rigorous capital project approval process for
the organization she led.
- Having served as a director of various public companies, brings
to the Board a strong corporate governance knowledge and a broad
set of skills in strategy development, M&A, global operations,
commercial experience, corporate governance and business turnaround
and growth.
- Previously served as President and Chief Executive Officer of
Tredegar Corporation, a global manufacturing company, and brings
deep leadership and directorship experience to Verso.
- Gained and developed extensive business, finance and leadership
skills, and possesses an understanding of strategic planning, risk
assessment and international operations.
Jay
Shuster
Verso Independent Director Since 2016,
since the Company emerged from bankruptcy
Mr. Shuster is a Managing Member
of Shuster Group, advising on strategic and operational planning,
M&A, and turnaround management issues.
- Lengthy career with Rock-Tenn Company (now WestRock) including
ten years in charge of all operations, provides an in-depth
understanding of the paper industry and business
- Substantial operational and financial management experience in
the paper products industry affords him insights into the complex
challenges and opportunities faced by Verso
- Service as a director of several companies in various
industries provides him with broad experiences increases knowledge
of effective corporate governance
- As a member of the Board since the Company's emergence from
bankruptcy in 2016, Mr. Shuster has played an integral role in
Verso's outperformance of both the Company's peer group and the
Russell 2000, with 49% stock appreciation over the last three
years
VOTE "FOR" ALL OF VERSO'S NOMINEES TO ENSURE
THE RIGHT MIX OF
SKILLS AND EXPERIENCE THAT WILL DELIVER VALUE AND DRIVE THE
FUTURE
VALUE OF YOUR INVESTMENT
Collectively, Verso's successful
and diverse director nominees have more than 150 years of paper
industry experience, and a range of operational, executive and
industry experience that will ensure the Board provides our company
and operations with the best oversight and strategic
counsel.
Our nominees bring deep experience
in areas that are critical to our operations and strategy,
including finance and M&A, organic growth strategic
transformation and governance. Several also have an intimate
understanding of the paper industry, including graphics papers,
specialty papers, bag papers, linerboard, medium, bleached and
unbleached boxboard, and market pulps, as well as extensive
experience in international markets.
In light of Verso's increased
focus on our graphics operations on a go-forward basis, we believe
the breadth and depth of experience of our nominees is essential to
Verso's ability to continue driving strong performance and
delivering value to stockholders.
VOTING "FOR" VERSO'S NOMINEES AND "FOR" THE
PIXELLE TRANSACTION
ON THE WHITE PROXY CARD IS THE ONLY WAY TO ENSURE YOU RECEIVE THE
PROCEEDS FROM THE PIXELLE TRANSACTION
There is only one rational
choice. Your vote "FOR" our director nominees and "FOR"
the Pixelle Transaction will help ensure that ALL Verso
stockholders reap the benefits of our positive momentum and
participate in the return of at least $225
million of proceeds from the Pixelle Transaction that we
have promised.
Please use the enclosed
WHITE proxy card to vote today "FOR" ALL seven of Verso's
nominees listed on the WHITE proxy card: Dr.
Robert K. Beckler, Paula H. J. Cholmondeley, Randy J. Nebel, Steven
D. Scheiwe, Jay Shuster,
Adam St. John and Nancy M. Taylor. Simply follow the easy
instructions on the enclosed proxy card to vote by telephone, by
Internet or by signing, dating and returning the WHITE proxy card
in the postage-paid envelope provided.
On behalf of the Verso Board and
management team, we thank you for your continued support and
dedication to our Company at this time.
Sincerely,
|
|
|
Dr. Robert K.
Beckler
|
Paula H. J.
Cholmondeley
|
Randy J.
Nebel
|
Steven D.
Scheiwe
|
|
|
|
|
|
|
|
|
|
|
Jay
Shuster
|
Adam St.
John
|
Nancy M.
Taylor
|
|
YOUR VOTE IS
EXTREMELY IMPORTANT
NO MATTER HOW MANY SHARES YOU OWN.
If you have questions or need assistance in
voting your WHITE proxy card
please contact:
MacKenzie Partners, Inc.
1407 Broadway, 27th Floor
New York, New York 10018
proxy@mackenziepartners.com
(212) 929-5500
or
Toll-Free (800) 322-2885
About Verso
Verso Corporation is the turn-to company
for those looking to successfully navigate the complexities of
paper sourcing and performance. A leading North American producer
of specialty and graphic papers, packaging and pulp, Verso provides
insightful solutions that help drive improved customer efficiency,
productivity, brand awareness and business results. Verso's
long-standing reputation for quality and reliability is directly
tied to our vision to be a company with passion that is respected
and trusted by all. Verso's passion is rooted in ethical business
practices that demand safe workplaces for our employees and
sustainable wood sourcing for our products. This passion, combined
with our flexible manufacturing capabilities and an unmatched
commitment to product performance, delivery and service, make Verso
a preferred choice among commercial printers, paper merchants and
brokers, converters, publishers and other end users. For more
information, visit us online at versoco.com.
Forward-Looking Statements
In this letter to
stockholders, all statements that are not purely historical facts
are forward-looking statements within the meaning of Section 27A of
the Securities Act of 1933, as amended, or "Securities Act," and
Section 21E of the Securities Exchange Act of 1934, as amended, or
"Exchange Act." Forward-looking statements may be identified by the
words "believe," "expect," "anticipate," "project," "plan,"
"estimate," "intend" and other similar expressions. They include,
for example, statements relating to our business and operating
outlook; assessment of market conditions; and the growth potential
of the industry in which we operate. Forward-looking statements are
based on currently available business, economic, financial and
other information and reflect management's current beliefs,
expectations and views with respect to future developments and
their potential effects on us. Actual results could vary materially
depending on risks and uncertainties that may affect us and our
business. The following factors, among others, could cause actual
results to differ from those set forth in the forward-looking
statements: the long-term structural decline and general softening
of demand facing the paper industry; our exploration of strategic
alternatives, including the possible sale or merger of our entire
company or a material portion of our business and our ability to
consummate any such strategic transactions, including the proposed
sale of our Androscoggin Mill and Stevens Point Mill; the risk that
the purchase agreement for the sale transaction would limit our
ability to pursue other strategic alternatives to the sale
transaction; the risk that the purchase agreement for the sale
transaction might expose us to contingent liabilities; risks
related to our ability to obtain stockholder approval for the sale
transaction; the risk that the pending sale transaction could
create unknown impacts on our future prospects; the risk that the
amount of net proceeds that we would receive from the sale
transaction is subject to uncertainties; the risk that stockholders
are not guaranteed to receive any of the proceeds from the sale
transaction; the risk that management could spend or invest the net
proceeds from the sale transaction in ways against stockholders'
wishes; the risk that some of our executive officers might have
interests in the sale transaction that might be in addition to, or
different from, stockholders' interests; the risk that our business
following the sale transaction would be reduced and less
diversified; the risk that we would be unable to compete with
respect to certain specialty paper products for two years after the
closing of the sale transaction; the risk that we may be unable to
obtain governmental and regulatory approvals required for the sale
transaction, or required governmental and regulatory approvals may
delay the transaction or result in the imposition of conditions
that could cause the parties to abandon the sale transaction; the
risk that an event, change or other circumstances could give rise
to the termination of the sale transaction; the risk that failure
to consummate the sale transaction might materially and adversely
affect our business, financial condition and results of operation;
the risk that a condition to closing of the sale transaction may
not be satisfied; the risk that we would be required to pay a
termination fee or expense reimbursement if the purchase agreement
for the sale transaction is terminated under specified
circumstances, which might discourage third parties from submitting
an alternative proposal; the timing to consummate the sale
transaction; the risk that any announcement relating to the sale
transaction could have adverse effects on the market price of our
common stock; the risk of and the outcome of any pending or
threatened litigation related to the sale transaction or the Annual
Meeting; the risk of disruption from the sale transaction making it
more difficult to maintain relationships with customers, employees
or suppliers; the diversion of management time on
transaction-related issues; our adoption of a limited duration
stockholder rights plan and its ability to delay or discourage a
merger, tender offer or change of control; negative effects of a
proxy contest and the actions of activist stockholders;
developments in alternative media, which have and are expected to
continue to adversely affect the demand for some of our key
products, and the effectiveness of our responses to these
developments; intense competition in the paper manufacturing
industry; our dependence on a small number of customers for a
significant portion of our business; any additional closure and
other restructuring costs; our limited ability to control the
pricing of our products or pass through increases in our costs to
our customers; changes in the costs of raw materials and purchased
energy; negative publicity, even if unjustified; any failure to
comply with environmental or other laws or regulations, even if
inadvertent; legal proceedings or disputes; any labor disputes; our
ability to continue to execute and implement our strategic plan;
our initiatives to improve our financial and operational
performance and increase our growth and profitability; our future
operational and financial performance; the effect that the election
of Atlas/Blue Wolf's nominees to our board of directors will have
on our execution of our long-term plan and long-term stockholder
value; the future effect of our strategic plan on our probability,
growth and stockholder return; and the potential risks and
uncertainties described in Part I, Item 1A, "Risk Factors" of our
Annual Report on Form 10-K for the year ended December 31, 2018, as amended, Part I, Item 2,
"Management's Discussion and Analysis of Financial Condition and
Results of Operations" Part II, Item 1A, "Risk Factors" of our
Quarterly Report on Form 10-Q for the quarter ended September 30, 2019, and "Risk Factors Relating to
the Sale Proposal" of our definitive proxy statement filed with the
SEC on December 30, 2019, as such
disclosures may be amended, supplemented or superseded from time to
time by other reports we file with the SEC, including subsequent
annual reports on Form 10-K and quarterly reports on Form 10-Q. We
assume no obligation to update any forward-looking statement made
in this letter to stockholders to reflect subsequent events or
circumstances or actual outcomes.
Additional Information and Where to Find It
In
connection with the solicitation of proxies concerning the matters
to be considered at the Annual Meeting, including the proposed sale
transaction, the Company has filed a definitive proxy statement,
WHITE proxy card and other materials with the SEC. WE URGE
INVESTORS TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR
SUPPLEMENTS THERETO), THE ACCOMPANYING WHITE PROXY CARD, AND ANY
OTHER MATERIALS FILED WITH THE SEC CAREFULLY BEFORE MAKING ANY
VOTING OR INVESTMENT DECISION BECAUSE THEY CONTAIN IMPORTANT
INFORMATION ABOUT THE MATTERS TO BE CONSIDERED AT THE ANNUAL
MEETING. Investors may obtain copies of these documents free of
charge at the SEC's website (www.sec.gov) and from the Company.
Participants in the Solicitation
The Company, its
directors, executive officers and other persons related to the
Company may be deemed to be participants in the solicitation of
proxies from the Company's stockholders in connection with the
matters to be considered at the Annual Meeting, including the
proposed sale transaction. Information about the directors and
executive officers of the Company and their ownership of Company
common stock is set forth in the definitive proxy statement for the
Annual Meeting. Other information regarding the participants in the
proxy solicitations and a description of their direct and indirect
interests, by security holdings or otherwise, is also in the
definitive proxy statement for the Annual Meeting and other
relevant materials to be filed with the SEC when such materials
become available.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/verso-mails-letter-to-stockholders-reiterating-the-significant-value-creation-and-return-of-capital-to-stockholders-by-the-board-and-management-team-300985439.html
SOURCE Verso Corporation